Share This

Topics Comments
Cheung Kong VODone Limited Shenzhen International Holdings Limited Jiangxi Copper Company Limited REXLot Holdings Limited China Overseas Land & Investment Limited Chong Hing Bank Limited Agricultural Bank of China Limited Chow Tai Fook Jewellery Group Limited Capital VC Limited iShares A50 Standard Chartered Bank of Communications Bank of China China LotSynergy Holdings Limited agribank Agri Airlines Appl AUD Auto A Shares Brokers CAD fertilizer producers China Lottery Supermarket China Banks Communication Consumer China Econ Electricity China Finance China IT Petro Real Est China Resource Steel coal Commodity Beauty Drugs Enviro EURO Lang Simon Ting WongSir Andy Xie Expo Gambling Garment gas GBD Gold Gold Jew Gold mine Harbour Highways HK Apparel REITs Rentals HK Banks ETF HK Housing Market Real Est HK HK Stock iBond Infra Insure IPO jewel Mach Build Mat New Energy NZD Oil Paper Rare Earths Real Estate Market Food RMB Rising RMB RMB Bonds Shipbuilding Shipping Sports Stock Trend Taiwan Dollar (TWD) Textile Top 500 USD US Econ Util Water Yang Liu's 10 Stocks YEN Diary media Central Bank Monetary Policy Education Construction Emerging markets Nuclear power BillGross Cement HK retail logistics Swiss franc Social Security Fund Law Ka-Chung capital flow Financial and political policy Railway film Korean Won Roubini Faber Mobius
Topics Last reply time Nickname Content
EC HEALTHCARE 2018-05-21T11:52 財經茄呢啡 醫思醫療（2138）與騰訊（700）旗下的企鵝醫生日前宣佈合作，醫思醫療今年將會在香港開設兩間「企鵝醫生」的全方位診所，2至3年內再開18間。醫思醫療獲騰訊作為醫療上的合作伙伴，足以證明醫思本身具過人之處，股價應聲急升。
EC HEALTHCARE 2018-05-21T11:52 財經茄呢啡 醫思醫療（2138）目前為全港最大的醫學美容服務提供商，同時亦提供一站式全方位體檢、健康產品、健康管理及傳統醫服務。企鵝醫生本身實行「互聯網＋實體醫療」雙線發展，對醫思前景發展大大有利。股價雖然急升，但略待回吐可再吸，之前低位吸納了的繼續長線持有。
EC HEALTHCARE 2018-05-17T11:10 財經茄呢啡 醫思醫療（2138）獲基金OrbiMed買入6,381萬股或6.49%，每股作價3.5元，涉資2.2億元。OrbiMed專注全球生物醫療領域投資超過20年，管理淨資產超過140億美元，非同小可。醫思醫療宣佈與騰訊（700）旗下企鵝醫生簽訂戰略合作協議，計劃聯手在港開設多家全科診所，將智慧診所醫療閉環模式引入本港醫療市場。
EC HEALTHCARE 2018-05-17T11:10 財經茄呢啡 醫思醫療（2138）主打醫學美容，截至去年9月底止中期收入增長51.4%至6.17億元，盈利則升73%至1.26億元。醫思醫療上市兩年，有每次業績均派息的優良紀錄，現價股息率近7厘。
EC HEALTHCARE 2017-10-06T09:43 財經茄呢啡 陳永陸 : 全港最大的醫學美容及健康管理服務的醫思醫療（2138）近日積極擴展高端體檢、醫學美容及傳統醫療業務。醫思醫療除了打造香港知名品牌DR REBORN外，更買了幾個香港的知名品牌，令市場市佔率及地位大大提升，預期2018年至2019年內地業務收入比例，將由現時25%增至介乎30%至35%，有助集團盈利保持高增長。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.